A protein tyrosine kinase inhibitor, imatinib mesylate (Gleevec), improves erectile and vascular function secondary to a reduction of hyperglycemia in diabetic rats.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples